An interventional study of Educational package in Cysticercosis, sponsored by University of Oklahoma. Completed at 1 site in Burkina Faso. Open to participants aged 5 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-03.
Sponsored by University of Oklahoma · Not applicable, Interventional, and Prevention
This is a pre-post randomized community-based controlled trial aimed at estimating the effectiveness of an educational package developed using PRECEDE PROCEED to reduce the cumulative incidence of Taenia solium cysticercosis in three Provinces of Burkina Faso. The study design included an 18-months baseline study to measure baseline cumulative incidence of cysticercosis followed by an 18-month post randomization study to measure the effectiveness of the intervention. Sixty villages of three Provinces of Burkina Faso were included. The primary outcome was the change in the baseline to post randomization cumulative incidence in the intervention group compared to the control group.
The unit of randomization and analysis of this study is the village. Therefore, the eligibility criteria were determined at the village level.
Inclusion Criteria:
Exclusion Criteria:
At the individual level, the following eligibility criteria were used:
Inclusion Criteria:
Exclusion Criteria:
The educational package included the offering of the Self-Esteem , Associative strengths, Resourcefulness, Action-planning and Responsibility (SARAR) Participatory Hygiene and Sanitation Transformation (PHAST) approach, a 52 minutes educational movie and accompanying cartoon booklet. The package was developed using the PRECEDE approach.
Other: Educational package
The control group did not receive any intervention
The educational package was offered to 30 villages post randomization. The field team completed the SARAR PHAST with community members for 2-3 days in each intervention village. The movie was projected every night for 2-3 days in each intervention village.
Human active cysticercosis cumulative incidence
Sero conversion to the AgELISA test to detect antigens of cysticercosis
Time frame: baseline, 18 months follow-up pre randomization, 18 months follow-up post randomization
Porcine active cysticercosis prevalence
Sero-positivity to the AgELISA test to detect antigens of cysticercosis
Time frame: baseline, 18 months follow-up pre randomization, 18 months follow-up post randomization
Change in knowledge, attitude and practices
Change in answers to the questionnaire through time
Time frame: baseline, 18 months follow-up pre randomization, 18 months follow-up post randomization
Cumulative incidence of epilepsy and progressively worsening severe chronic headaches
development of neurological disorders among those followed up at least twice
Time frame: baseline, 18 months follow-up pre randomization, 18 months follow-up post randomization
Stigmatization of epilepsy
Attitudes and knowledge regarding epilepsy post randomization
Time frame: 18 months follow-up post randomization
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — De-identified data will be made available at the time of publication as per NIH requirements
This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Oklahoma